4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-051925
Director sold 7,495 shares at an average $21.97 ($164,665)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waddill William D. Director | 2024-12-16 | Sale 10b5-1 | −3,748 | $21.90 | $82,081 | 44,125 | D |
| Waddill William D. Director | 2024-12-17 | Sale 10b5-1 | −3,747 | $22.04 | $82,584 | 40,378 | D |
| Open-market sales · 7,495 sh · avg $21.97 · $164,665 | |||||||
Loading xslF345X05/wk-form4_1734563946.xml…